Cargando…
Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells
Metformin is a widely prescribed anti-diabetes drug with potential utilities for cancer therapies. Several studies have related metformin to the reduced risk of cholangiocarcinoma (CCA), highlighting its potentialities for the treatments of CCA. However, the underlying molecular mechanisms remain el...
Autores principales: | Zhang, Jin, Hang, Caihua, Jiang, Ting, Yi, Shenghui, Shao, Wei, Li, Wengang, Lin, Donghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735195/ https://www.ncbi.nlm.nih.gov/pubmed/33330044 http://dx.doi.org/10.3389/fonc.2020.570516 |
Ejemplares similares
-
Nuclear magnetic resonance‐based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis
por: Gu, Jinping, et al.
Publicado: (2020) -
Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection
por: Li, Qian, et al.
Publicado: (2022) -
Interventional Treatment for Cholangiocarcinoma
por: Li, Hang, et al.
Publicado: (2021) -
Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics
por: Quintero Escobar, Melissa, et al.
Publicado: (2020) -
Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages
por: Li, Zhuofei, et al.
Publicado: (2022)